Skip to content

Jennifer Xiao

3 papers in the library · 38 citations · publishing 2025

Papers

Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder.

JAMA psychiatry February 1, 2025 Daniel T Myran, Michael Pugliese, Jennifer Xiao et al. 23 citations

People who had an emergency department visit involving hallucinogen use were more likely to be diagnosed with a schizophrenia spectrum disorder within three years compared with the general population (3.99% vs 0.15%). After accounting for other substance use and mental health conditions, the risk remained elevated: they were about 3.5 times as likely as the general population, 4.7 times as likely as those with an alcohol-related ED visit, and 1.5 times as likely as those with a cannabis-related ED visit. The rate of hallucinogen-related ED visits rose 86% between 2013 and 2021.

Mortality risk among people receiving acute hospital care for hallucinogen use compared with the general population.

CMAJ March 2, 2025 Daniel T. Myran, Jennifer Xiao, Nicholas Fabiano et al. 8 citations

People who had an emergency department visit or hospital admission involving hallucinogen use in Ontario, Canada, between 2006 and 2022 had a 2.6-fold higher risk of death from any cause within five years compared with the general population. Among 7953 individuals with such acute care, 6.1% died within five years versus 0.6% in the matched general population. Elevated risks were also seen for death from unintentional drug poisoning, suicide, respiratory disease, and cancer. These associations persisted even after excluding people with other mental or substance use disorders.

Psilocybin Dispensaries and Online Health Claims in Canada

JAMA Network Open April 1, 2025 Jenna Matsukubo, Sarah Dickson, Jennifer Xiao et al. 7 citations

As of May 2024, 57 psilocybin dispensaries operated in Canada, located in 15 of 42 major cities (35.7%) and concentrated in Ontario and British Columbia. Most stores (61.4%) were part of a chain, 91.2% had an online presence, and all sold dried mushrooms, with many also offering microdosing capsules, chocolates, and gummies. 65.2% sold products mimicking popular food brands. Among stores with websites, 86.4% claimed mental health benefits such as alleviating anxiety, yet warnings about driving, pregnancy, or history of psychosis were rare (9.1%, 13.6%, and 31.8% respectively). The findings suggest a need for greater regulatory measures to protect the public.